🇪🇺 99mTc-Etarfolatide in European Union

EMA authorised 99mTc-Etarfolatide on 21 March 2014

Marketing authorisation

EMA — authorised 21 March 2014

  • Application: EMEA/H/C/002570
  • Marketing authorisation holder: Endocyte Europe, B.V.
  • Local brand name: Folcepri
  • Indication: Indicated for single photon emission computed tomography (SPECT) imaging
  • Pathway: orphan
  • Status: withdrawn

Read official source →

Other Oncology approved in European Union

Frequently asked questions

Is 99mTc-Etarfolatide approved in European Union?

Yes. EMA authorised it on 21 March 2014.

Who is the marketing authorisation holder for 99mTc-Etarfolatide in European Union?

Endocyte Europe, B.V. holds the EU marketing authorisation.